Could This Send Moderna's Stock Soaring Back to $400?

Shares of Moderna (NASDAQ: MRNA) have been plummeting in recent months. As concerns shift from COVID-19 and onto inflation, investors have become less bullish on Moderna's stock. Omicron was a significant variant when it emerged in November, and that prompted Moderna to create a booster shot which targeted that variant.